Financial Ratios 3M Company

Stocks

MMM

US88579Y1010

Consumer Goods Conglomerates

Market Closed - NYSE Other stock markets 04:02:45 2026-07-10 pm EDT			5-day change	1st Jan Change
157.52 ^USD	+1.40%		-1.82%	-1.61%

Jul. 09	NY Attorney General Sues 3M, Others Over 'Forever Chemicals'	DJ
Jul. 09	3M, DuPont, Corteva, Chemours Sued by New York AG Over Toxic Pollution From Consumer Products	MT

3ed7f81663159e37.L7NgjUyAAt4LtkpZpCHCtPadxt2SmguRAuE0Ra5pl3o.esI5uHvkM4RAwRMt50yz97zXi-TD6lOkUI0DCs8DohBk9xKgNehljUKFeg

Published financial data: 3M COMPANY

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	35.36B	34.23B	32.68B	24.58B	24.95B
Total Revenues	35.36B	34.23B	32.68B	24.58B	24.95B
Cost of Goods Sold, Total	18.78B	19.23B	18.38B	14.42B	14.99B
Gross Profit	16.58B	15B	14.3B	10.16B	9.96B
Selling General & Admin Expenses, Total	6.81B	7.84B	6.61B	4.91B	4.08B
R&D Expenses	1.98B	1.85B	1.81B	1.07B	1.17B
Other Operating Expenses, Total	8.79B	9.7B	8.42B	5.98B	5.25B
Operating Income	7.79B	5.3B	5.88B	4.18B	4.71B
Interest Expense, Total	-488M	-462M	-942M	-1.19B	-946M
Interest And Investment Income	26M	67M	253M	452M	232M
Net Interest Expenses	-462M	-395M	-689M	-739M	-714M
Income (Loss) On Equity Invest.	10M	11M	18M	9M	52M
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	7.34B	4.92B	5.21B	3.45B	4.05B
Restructuring Charges	-124M	-968M	-419M	-187M	-21M
Impairment of Goodwill	-	-271M	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	1.56B	402M
Gain (Loss) On Sale Of Assets	-	2.72B	36M	-	-162M
Legal Settlements	-	-	-14.5B	-	-
EBT, Incl. Unusual Items	7.21B	6.4B	-9.67B	4.83B	4.26B
Income Tax Expense	1.28B	612M	-2.69B	804M	1B
Earnings From Continuing Operations	5.93B	5.79B	-6.98B	4.02B	3.26B
Earnings Of Discontinued Operations	-	-	-	164M	-
Net Income to Company	5.93B	5.79B	-6.98B	4.19B	3.26B
Minority Interest	-8M	-14M	-16M	-15M	-12M
Net Income - (IS)	5.92B	5.78B	-7B	4.17B	3.25B
Net Income to Common Incl Extra Items	5.92B	5.78B	-7B	4.17B	3.25B
Net Income to Common Excl. Extra Items	5.92B	5.78B	-7B	4.01B	3.25B
Per Share Items
Net EPS - Basic	10.23	10.21	-12.63	7.58	6.05
Basic EPS - Continuing Operations	10.23	10.21	-12.63	7.28	6.05
Basic Weighted Average Shares Outstanding	579M	566M	554M	551M	537M
Net EPS - Diluted	10.12	10.18	-12.63	7.56	6
Diluted EPS - Continuing Operations	10.12	10.18	-12.63	7.26	6
Diluted Weighted Average Shares Outstanding	585M	568M	554M	552M	541M
Normalized Basic EPS	7.91	5.41	5.85	3.89	4.68
Normalized Diluted EPS	7.82	5.39	5.85	3.88	4.65
Dividend Per Share	5.92	5.96	6	3.61	2.92
Payout Ratio	57.76	58.32	-47.33	47.5	48.06
American Depositary Receipts Ratio (ADR)	0.25	0.25	0.25	0.25	0.25
Supplemental Items
EBITDA	9.7B	7.13B	7.87B	5.36B	6.02B
EBITA	8.32B	5.8B	6.37B	4.29B	4.81B
EBIT	7.79B	5.3B	5.88B	4.18B	4.71B
EBITDAR	10.15B	7.56B	8.28B	5.68B	6.32B
Effective Tax Rate - (Ratio)	17.81	9.56	27.83	16.65	23.52
Current Domestic Taxes	860M	682M	454M	-81M	-12M
Current Foreign Taxes	597M	621M	679M	583M	597M
Total Current Taxes	1.46B	1.3B	1.13B	502M	585M
Deferred Domestic Taxes	-244M	-688M	-3.58B	329M	328M
Deferred Foreign Taxes	72M	-2M	-246M	-27M	90M
Total Deferred Taxes	-172M	-690M	-3.82B	302M	418M
Normalized Net Income	4.58B	3.06B	3.24B	2.14B	2.52B
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	2M	2M	-	-	-
Non-Cash Pension Expense	-288M	-239M	-117M	814M	86M
Supplemental Operating Expense Items
Advertising Expense	327M	323M	265M	216M	233M
Research And Development Expense From Footnotes	1.99B	1.86B	1.84B	1.08B	1.17B
Net Rental Expense, Total	446M	430M	406M	324M	308M
Imputed Operating Lease Interest Expense	91.42M	90.34M	181M	203M	174M
Imputed Operating Lease Depreciation	355M	340M	225M	121M	134M
Stock-Based Comp., COGS (Total)	47M	48M	44M	39M	32M
Stock-Based Comp., R&D Exp. (Total)	42M	46M	44M	44M	35M
Stock-Based Comp., SG&A Exp. (Total)	185M	169M	186M	185M	158M
Stock-Based Comp., Other (Total)	-	-	-	21M	-
Total Stock-Based Compensation	274M	263M	274M	289M	225M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	4.56B	3.66B	5.93B	5.6B	5.24B
Short Term Investments	201M	238M	53M	2.13B	2.7B
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	4.76B	3.89B	5.99B	7.73B	7.93B
Accounts Receivable, Total	4.66B	4.53B	4.75B	3.19B	3.53B
Other Receivables	110M	103M	114M	78M	-
Total Receivables	4.77B	4.64B	4.86B	3.27B	3.53B
Inventory	4.98B	5.37B	4.82B	3.7B	3.66B
Prepaid Expenses	654M	435M	485M	436M	391M
Other Current Assets, Total	229M	353M	222M	750M	869M
Total Current Assets	15.4B	14.69B	16.38B	15.88B	16.39B
Gross Property Plant And Equipment	28.07B	26.83B	27.63B	23.97B	24.44B
Accumulated Depreciation	-17.78B	-16.82B	-17.71B	-16.02B	-16.82B
Net Property Plant And Equipment	10.29B	10.01B	9.92B	7.95B	7.62B
Long-term Investments	262M	967M	244M	2.5B	-
Goodwill	13.49B	12.79B	12.93B	6.28B	6.42B
Other Intangibles, Total	5.29B	4.7B	4.23B	1.21B	1.1B
Deferred Tax Assets Long-Term	581M	959M	4.92B	4.15B	3.83B
Other Long-Term Assets, Total	1.76B	2.34B	1.97B	1.89B	2.38B
Total Assets	47.07B	46.46B	50.58B	39.87B	37.73B
Liabilities
Accounts Payable, Total	2.99B	3.18B	3.24B	2.66B	2.7B
Accrued Expenses, Total	2.37B	1.99B	2.26B	1.76B	2.04B
Short-term Borrowings	16M	-	1.8B	-	-
Current Portion of Long-Term Debt	1.29B	1.94B	1.15B	1.92B	1.67B
Current Portion of Leases	270M	272M	225M	163M	167M
Current Income Taxes Payable	260M	259M	365M	331M	-
Unearned Revenue Current, Total	529M	538M	572M	15M	-
Other Current Liabilities	1.3B	1.34B	5.68B	4.41B	3.01B
Total Current Liabilities	9.04B	9.52B	15.3B	11.26B	9.6B
Long-Term Debt	16.06B	14B	13.18B	11.12B	10.93B
Long-Term Leases	684M	655M	594M	452M	363M
Unearned Revenue Non Current	-	-	-	-	-
Pension & Other Post Retirement Benefits	3.27B	2.35B	2.8B	2.14B	1.63B
Deferred Tax Liability Non Current	458M	559M	528M	354M	418M
Other Non Current Liabilities	2.45B	4.6B	13.31B	10.65B	10.05B
Total Liabilities	31.96B	31.68B	45.71B	35.97B	32.99B
Common Stock, Total	9M	9M	9M	9M	9M
Additional Paid In Capital	6.43B	6.69B	6.96B	7.23B	7.44B
Retained Earnings	45.82B	47.95B	37.48B	36.8B	38.26B
Treasury Stock	-30.46B	-33.26B	-32.86B	-34.46B	-35.94B
Comprehensive Income and Other	-6.75B	-6.67B	-6.78B	-5.73B	-5.07B
Total Common Equity	15.05B	14.72B	4.81B	3.84B	4.7B
Minority Interest	71M	48M	61M	52M	45M
Total Equity	15.12B	14.77B	4.87B	3.89B	4.75B
Total Liabilities And Equity	47.07B	46.46B	50.58B	39.87B	37.73B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	571M	550M	553M	543M	527M
ECS Total Common Shares Outstanding	572M	549M	553M	539M	530M
Book Value / Share	26.31	26.8	8.7	7.12	8.87
Tangible Book Value	-3.73B	-2.77B	-12.35B	-3.65B	-2.82B
Tangible Book Value Per Share	-6.52	-5.04	-22.34	-6.76	-5.32
Total Debt	18.32B	16.87B	16.94B	13.66B	13.13B
Net Debt	13.55B	12.97B	10.96B	5.93B	5.2B
Debt Equivalent of Unfunded Proj. Benefit Obligation	1.08B	38M	380M	-97M	-348M
Debt Equivalent Oper. Leases	3.57B	3.44B	3.25B	2.59B	2.46B
Minority Interest, Total (Incl. Fin. Div)	71M	48M	61M	52M	45M
Equity Method Investments, Total	129M	81M	74M	75M	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	1.21B	1.27B	1.1B	798M	791M
Inventories - Work In Process, Total	1.58B	1.61B	1.42B	1.05B	1.13B
Inventories - Finished Goods, Total	2.2B	2.5B	2.29B	1.85B	1.74B
Land - (BS)	312M	255M	255M	200M	202M
Buildings, Total	8.09B	7.56B	7.91B	7.43B	7.73B
Machinery, Total	17.3B	16.46B	16.86B	14.78B	15.33B
Full Time Employees	95K	92K	85K	61.5K	60.5K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	189M	174M	141M	60M	61M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	5.92B	5.78B	-7B	4.17B	3.25B
Depreciation & Amortization - CF	1.39B	1.33B	1.5B	1.07B	1.2B
Amortization of Goodwill and Intangible Assets - (CF)	529M	498M	482M	108M	104M
Depreciation & Amortization, Total	1.92B	1.83B	1.99B	1.18B	1.31B
(Gain) Loss From Sale Of Asset	-	-2.72B	-36M	-	162M
Asset Writedown & Restructuring Costs	-	889M	-	44M	-
Stock-Based Compensation (CF)	274M	263M	274M	289M	225M
Net Cash From Discontinued Operations	-	-	-	139M	-
Other Operating Activities, Total	95M	225M	-3.85B	1.22B	557M
Change In Accounts Receivable	-122M	-105M	-170M	114M	-211M
Change In Inventories	-903M	-629M	567M	41M	139M
Change In Accounts Payable	518M	111M	138M	46M	21M
Change In Income Taxes	-244M	-47M	-218M	-272M	-
Change in Other Net Operating Assets	-	-	14.98B	-5.15B	-3.14B
Cash from Operations	7.45B	5.59B	6.68B	1.82B	2.31B
Capital Expenditure	-1.6B	-1.75B	-1.62B	-1.18B	-910M
Sale of Property, Plant, and Equipment	51M	200M	119M	61M	95M
Cash Acquisitions	-	-	-	-	-
Divestitures	-	491M	60M	-	5M
Investment in Marketable and Equity Securities, Total	204M	11M	194M	-2.08B	2.16B
Other Investing Activities, Total	31M	1M	35M	-7M	-3M
Cash from Investing	-1.32B	-1.05B	-1.21B	-3.21B	1.35B
Short Term Debt Issued, Total	-	340M	205M	-	-
Long-Term Debt Issued, Total	1M	1M	2.84B	8.37B	1.1B
Total Debt Issued	1M	341M	3.04B	8.37B	1.1B
Short Term Debt Repaid, Total	-2M	-	-	-205M	-
Long-Term Debt Repaid, Total	-1.14B	-1.18B	-3.09B	-2.66B	-1.82B
Total Debt Repaid	-1.15B	-1.18B	-3.09B	-2.86B	-1.82B
Issuance of Common Stock	639M	381M	264M	92M	1.56B
Repurchase of Common Stock	-2.2B	-1.46B	-33M	-1.8B	-3.25B
Common Dividends Paid	-3.42B	-3.37B	-3.31B	-1.98B	-1.56B
Common & Preferred Stock Dividends Paid	-3.42B	-3.37B	-3.31B	-1.98B	-1.56B
Other Financing Activities, Total	-20M	-60M	-21M	-717M	-49M
Cash from Financing	-6.14B	-5.35B	-3.15B	1.1B	-4.02B
Foreign Exchange Rate Adjustments	-62M	-104M	-48M	-44M	41M
Miscellaneous Cash Flow Adjustments	-	-	-	-	-46M
Net Change in Cash	-70M	-909M	2.28B	-333M	-365M
Supplemental Items
Cash Interest Paid	472M	440M	520M	505M	467M
Cash Income Tax Paid (Refund)	1.7B	1.32B	1.38B	852M	800M
Levered Free Cash Flow	5.04B	3.07B	8.94B	1.61B	1.26B
Unlevered Free Cash Flow	5.35B	3.36B	9.53B	2.36B	1.85B
Change In Net Working Capital	107M	302M	-5.2B	546M	1.71B
Net Debt Issued / Repaid	-1.14B	-838M	-46M	5.51B	-716M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	10.31	7.09	7.58	5.78	7.58
Return on Total Capital	14.72	10.19	13.74	13.34	16.59
Return On Equity %	42.28	38.75	-71.08	91.85	75.5
Return on Common Equity	42.42	38.81	-71.64	92.7	76.08
Margin Analysis
Gross Profit Margin %	46.89	43.82	43.77	41.33	39.92
SG&A Margin	19.27	22.92	20.23	19.97	16.36
EBITDA Margin %	27.45	20.84	24.08	21.81	24.11
EBITA Margin %	23.53	16.94	19.48	17.45	19.29
EBIT Margin %	22.03	15.49	18	17.01	18.87
Income From Continuing Operations Margin %	16.77	16.92	-21.35	16.37	13.08
Net Income Margin %	16.75	16.88	-21.4	16.98	13.03
Net Avail. For Common Margin %	16.75	16.88	-21.4	16.31	13.03
Normalized Net Income Margin	12.95	8.94	9.92	8.72	10.09
Levered Free Cash Flow Margin	14.26	8.96	27.35	6.55	5.05
Unlevered Free Cash Flow Margin	15.13	9.81	29.15	9.58	7.42
Asset Turnover
Asset Turnover	0.75	0.73	0.67	0.54	0.64
Fixed Assets Turnover	3.44	3.37	3.28	3.02	3.2
Receivables Turnover (Average Receivables)	7.55	7.45	7.04	7.23	7.42
Inventory Turnover (Average Inventory)	4.07	3.71	3.61	3.77	4.07
Short Term Liquidity
Current Ratio	1.7	1.54	1.07	1.41	1.71
Quick Ratio	1.06	0.9	0.71	0.98	1.19
Operating Cash Flow to Current Liabilities	0.83	0.59	0.44	0.16	0.24
Days Sales Outstanding (Average Receivables)	48.34	49.01	51.83	50.6	49.21
Days Outstanding Inventory (Average Inventory)	89.66	98.3	101.24	97	89.59
Average Days Payable Outstanding	51.93	57.47	65.81	70.2	65.44
Cash Conversion Cycle (Average Days)	86.07	89.84	87.27	77.4	73.36
Long Term Solvency
Total Debt/Equity	121.17	114.19	348.03	350.77	276.64
Total Debt / Total Capital	54.79	53.31	77.68	77.82	73.45
LT Debt/Equity	110.74	99.23	282.87	297.3	237.94
Long-Term Debt / Total Capital	50.07	46.33	63.14	65.95	63.17
Total Liabilities / Total Assets	67.89	68.21	90.38	90.23	87.42
EBIT / Interest Expense	15.96	11.48	6.25	3.51	4.98
EBITDA / Interest Expense	20.8	16.37	8.79	4.77	6.68
(EBITDA - Capex) / Interest Expense	17.52	12.58	7.07	3.78	5.72
Total Debt / EBITDA	1.8	2.23	2.05	2.4	2.08
Net Debt / EBITDA	1.34	1.72	1.32	1.04	0.82
Total Debt / (EBITDA - Capex)	2.14	2.9	2.54	3.03	2.43
Net Debt / (EBITDA - Capex)	1.59	2.23	1.64	1.32	0.96
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	9.85	-3.18	-4.52	-0.14	1.52
Gross Profit, 1 Yr. Growth %	5.7	-9.52	-4.61	4.55	-1.97
EBITDA, 1 Yr. Growth %	7.04	-26.5	-4.87	-6.11	11.3
EBITA, 1 Yr. Growth %	8.14	-30.28	-8.28	-2.7	12.19
EBIT, 1 Yr. Growth %	8.86	-31.94	-8.68	-2.34	12.6
Earnings From Cont. Operations, 1 Yr. Growth %	8.73	-2.33	-220.51	-147.98	-18.94
Net Income, 1 Yr. Growth %	8.66	-2.43	-221.08	-159.66	-22.12
Normalized Net Income, 1 Yr. Growth %	10.24	-33.17	-14.07	-4.34	17.5
Diluted EPS Before Extra, 1 Yr. Growth %	8.12	0.59	-224.07	-147.86	-17.36
Accounts Receivable, 1 Yr. Growth %	-0.96	-2.75	4.81	-11.3	10.61
Inventory, 1 Yr. Growth %	17.6	7.76	-10.24	-6.24	-1
Net Property, Plant and Equip., 1 Yr. Growth %	0.02	-2.72	-0.89	-4.72	-4.22
Total Assets, 1 Yr. Growth %	-0.57	-1.31	8.88	-21.18	-5.36
Tangible Book Value, 1 Yr. Growth %	-44.93	-25.78	346.19	25.91	-22.72
Common Equity, 1 Yr. Growth %	16.93	-2.15	-67.35	-20.07	22.38
Cash From Operations, 1 Yr. Growth %	-8.12	-24.99	19.48	-72.77	26.77
Capital Expenditures, 1 Yr. Growth %	6.8	9.11	-7.66	-26.87	-22.95
Levered Free Cash Flow, 1 Yr. Growth %	-17.36	-39.16	135.69	-77.66	-23.84
Unlevered Free Cash Flow, 1 Yr. Growth %	-16.86	-37.23	133.44	-69.8	-22.83
Dividend Per Share, 1 Yr. Growth %	0.68	0.68	0.67	-39.83	-19.11
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	4.89	3.13	-3.86	-3.08	0.68
Gross Profit, 2 Yr. CAGR %	4.88	-2.21	-7.06	-0.73	1.24
EBITDA, 2 Yr. CAGR %	10.85	-11.3	-9.78	6.77	-17.17
EBITA, 2 Yr. CAGR %	11.88	-13.17	-12.33	9.55	-30.89
EBIT, 2 Yr. CAGR %	11.15	-13.92	-12.89	10.1	-32.06
Earnings From Cont. Operations, 2 Yr. CAGR %	14.42	3.05	8.49	-0.04	-37.63
Net Income, 2 Yr. CAGR %	14.49	2.97	8.69	-15.01	-31.84
Normalized Net Income, 2 Yr. CAGR %	10.92	-14.16	-15.64	6.16	-39.22
Diluted EPS Before Extra, 2 Yr. CAGR %	14.49	4.29	11.71	1.33	-37.11
Accounts Receivable, 2 Yr. CAGR %	-1.38	-1.86	0.96	-16.05	-0.95
Inventory, 2 Yr. CAGR %	9.81	12.57	-1.65	-17.03	-3.65
Net Property, Plant and Equip., 2 Yr. CAGR %	0.47	-1.36	-1.81	-10.85	-4.47
Total Assets, 2 Yr. CAGR %	2.67	-0.94	3.66	-7.36	-13.63
Tangible Book Value, 2 Yr. CAGR %	-38.2	-36.07	81.98	14.84	-1.36
Common Equity, 2 Yr. CAGR %	22.28	6.97	-43.48	-48.91	-1.1
Cash From Operations, 2 Yr. CAGR %	2.68	-16.99	-5.33	-42.96	-41.25
Capital Expenditures, 2 Yr. CAGR %	-2.87	7.95	0.37	-17.83	-24.94
Levered Free Cash Flow, 2 Yr. CAGR %	13.05	-29.09	33.43	9.48	-17.17
Unlevered Free Cash Flow, 2 Yr. CAGR %	12.5	-27.76	33.75	20.11	21.77
Dividend Per Share, 2 Yr. CAGR %	1.38	0.68	0.67	-22.17	-30.24
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	2.57	2.13	0.51	-11.42	-1.57
Gross Profit, 3 Yr. CAGR %	0.96	-0.16	-3.02	-15.03	-1.14
EBITDA, 3 Yr. CAGR %	1.6	-3.34	-4.61	-17.85	8.55
EBITA, 3 Yr. CAGR %	1.24	-4.44	-6.12	-19.7	10.42
EBIT, 3 Yr. CAGR %	0.1	-5.61	-6.32	-18.61	10.93
Earnings From Cont. Operations, 3 Yr. CAGR %	3.4	8.54	8.57	-12.12	-6.78
Net Income, 3 Yr. CAGR %	3.44	8.55	8.68	-11.01	-17.45
Normalized Net Income, 3 Yr. CAGR %	-0.63	-6.31	-7.92	-22.24	9.82
Diluted EPS Before Extra, 3 Yr. CAGR %	4.41	9.66	10.5	-10.48	-5.32
Accounts Receivable, 3 Yr. CAGR %	-2.45	-1.84	0.32	-11.83	-7.97
Inventory, 3 Yr. CAGR %	4.52	9.12	4.39	-9.48	-12
Net Property, Plant and Equip., 3 Yr. CAGR %	5.59	-0.61	-1.2	-8.22	-8.7
Total Assets, 3 Yr. CAGR %	8.85	1.32	2.23	-5.39	-6.7
Tangible Book Value, 3 Yr. CAGR %	8.58	-34.31	22.17	-0.71	0.63
Common Equity, 3 Yr. CAGR %	15.38	13.52	-27.98	-36.56	-31.64
Cash From Operations, 3 Yr. CAGR %	5	-7.53	-6.27	-37.51	-25.56
Capital Expenditures, 3 Yr. CAGR %	0.55	0.97	2.47	-9.68	-19.57
Levered Free Cash Flow, 3 Yr. CAGR %	2.45	-8.04	13.57	-31.54	-2.12
Unlevered Free Cash Flow, 3 Yr. CAGR %	2.9	-7.39	13.99	-23.81	4.28
Dividend Per Share, 3 Yr. CAGR %	2.86	1.14	0.68	-15.2	-21.17
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	3.26	1.57	-0.05	-5.22	-4.97
Gross Profit, 5 Yr. CAGR %	2.03	-0.89	-2.35	-7.59	-8.69
EBITDA, 5 Yr. CAGR %	2.48	-3.83	-3.19	-7.46	-7.88
EBITA, 5 Yr. CAGR %	2.44	-5.19	-4.5	-8.39	-8.96
EBIT, 5 Yr. CAGR %	1.84	-6.28	-5.4	-7.89	-8.03
Earnings From Cont. Operations, 5 Yr. CAGR %	3.23	3.53	5.41	-2.34	-9.77
Net Income, 5 Yr. CAGR %	3.23	3.53	5.51	-1.57	-9.82
Normalized Net Income, 5 Yr. CAGR %	1.12	-7.02	-7.02	-10.46	-9.53
Diluted EPS Before Extra, 5 Yr. CAGR %	4.4	5.12	7.28	-1.22	-8.51
Accounts Receivable, 5 Yr. CAGR %	1.19	-1.59	-1.1	-7.79	-5.57
Inventory, 5 Yr. CAGR %	8.05	5.9	2.01	-2.2	-2.89
Net Property, Plant and Equip., 5 Yr. CAGR %	3.85	2.45	2.57	-4.84	-5.83
Total Assets, 5 Yr. CAGR %	7.42	4.11	6.74	-2.24	-4.44
Tangible Book Value, 5 Yr. CAGR %	25.7	7.97	33.5	-17.86	-16.07
Common Equity, 5 Yr. CAGR %	7.88	4.95	-13.27	-17.52	-18.24
Cash From Operations, 5 Yr. CAGR %	2.27	-2.17	0.74	-23.78	-22.24
Capital Expenditures, 5 Yr. CAGR %	2.45	4.96	0.48	-7.02	-9.52
Levered Free Cash Flow, 5 Yr. CAGR %	0.71	-5.89	13.77	-16.4	-27.05
Unlevered Free Cash Flow, 5 Yr. CAGR %	1.39	-5.08	14.18	-11.03	-22.05
Dividend Per Share, 5 Yr. CAGR %	5.92	4.86	1.98	-8.92	-13.06